Co-Founder and former CEO, Intellikine
Partner, Latham & Watkins
Professor, MIT
General Partner, Flybridge Capital Partners
Co-Founder, Fate Therapeutics
Prof. Dept. of Medicine/Hematology, Univ. of Washington
Partner, ARCH Venture Partners
Chairman of the Board, Oncothyreon
|
|